A recent study found that a non-invasive test based on carbon monoxide could help diagnose HDFN earlier and improve outcomes.

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Kozhikode: A preliminary study conducted by the National Institute of Virology (NIV) in Pune indicates that there has been no ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.

While the district officer initially submitted a report about 21 children being diagnosed with jaundice, he did not disclose ...